Cargando…
Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase
Influenza subtypes such as H7 have pandemic potential since they are able to infect humans with severe consequences, as evidenced by the ongoing H7N9 infections in China that began in 2013. The diversity of H7 viruses calls for a broadly cross-protective vaccine for protection. We describe the const...
Autores principales: | Meseda, Clement A., Atukorale, Vajini, Soto, Jackeline, Eichelberger, Maryna C., Gao, Jin, Wang, Wei, Weiss, Carol D., Weir, Jerry P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876369/ https://www.ncbi.nlm.nih.gov/pubmed/29599502 http://dx.doi.org/10.1038/s41598-018-23712-9 |
Ejemplares similares
-
Stability of the HSV-2 US-6 Gene in the del II, del III, CP77, and I8R-G1L Sites in Modified Vaccinia Virus Ankara After Serial Passage of Recombinant Vectors in Cells
por: Atukorale, Vajini N., et al.
Publicado: (2020) -
Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge
por: Schmeisser, Falko, et al.
Publicado: (2015) -
Label‐free mass spectrometry‐based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines
por: Getie‐Kebtie, Melkamu, et al.
Publicado: (2012) -
Neutralizing and protective murine monoclonal antibodies to the hemagglutinin of influenza H5 clades 2.3.2.1 and 2.3.4.4
por: Schuele, Carlotta, et al.
Publicado: (2023) -
Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus
por: Di Mario, Giuseppina, et al.
Publicado: (2017)